Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:02 am Unchanged | 2026-06-30 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Armistice Capital, LLC | 3,398,000 6.720% | 0 (Unchanged) | Filing History |
| 2026-05-15 11:07 am Purchase | 2026-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Armistice Capital, LLC | 3,398,000 6.750% | 162,000 (+5.01%) | Filing History |
| 2026-05-15 09:15 am Purchase | 2026-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | LONG FOCUS CAPITAL MANAGEMENT, LLC | 3,310,687 6.600% | 3,310,687 (New Position) | Filing History |
| 2026-05-04 1:56 pm Sale | 2026-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Invus Public Equities, L.P. | 1,560,882 3.100% | -1,588,167 (-50.43%) | Filing History |
| 2026-03-04 12:45 pm Unchanged | 2026-02-28 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-03-03 5:39 pm Purchase | 2026-02-25 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Invus Public Equities, L.P. | 3,149,049 6.300% | 3,149,049 (New Position) | Filing History |
| 2026-03-03 5:27 pm Unchanged | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-03-03 5:25 pm Sale | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | -3,016,026 (Position Closed) | Filing History |
| 2026-02-18 4:47 pm Purchase | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Armistice Capital, LLC | 3,236,000 6.480% | 951,619 (+41.66%) | Filing History |
| 2026-02-11 10:57 am Purchase | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,016,026 6.040% | 405,689 (+15.54%) | Filing History |
| 2025-08-14 8:57 pm Sale | 2025-06-30 | 13G | BIO-KEY INTL INC PAR $0.00 BKYI | Armistice Capital, LLC | 35,970 4.990% | -23,670 (-39.69%) | Filing History |
| 2025-08-14 4:45 pm Sale | 2025-06-30 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Point72 Asset Management, L.P. | 1,860,317 3.900% | -1,879,001 (-50.25%) | Filing History |
| 2025-08-14 08:45 am Sale | 2025-06-30 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital, LP | 1,203,244 2.420% | -1,617,927 (-57.35%) | Filing History |
| 2025-05-15 4:34 pm Sale | 2025-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Point72 Asset Management, L.P. | 3,739,318 7.800% | -490,984 (-11.61%) | Filing History |
| 2025-05-15 3:08 pm Purchase | 2025-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Armistice Capital, LLC | 2,672,000 5.590% | 2,672,000 (New Position) | Filing History |
| 2025-05-15 08:37 am Sale | 2025-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital, LP | 2,821,171 5.670% | -509,065 (-15.29%) | Filing History |
| 2025-02-14 08:41 am Sale | 2024-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital, LP | 3,330,236 6.710% | -160,270 (-4.59%) | Filing History |
| 2025-02-11 09:09 am Purchase | 2024-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 2,610,337 5.490% | 2,610,337 (New Position) | Filing History |
| 2024-12-20 4:05 pm Purchase | 2024-12-13 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Point72 Asset Management, L.P. | 4,230,302 8.900% | 3,209,134 (+314.26%) | Filing History |
| 2024-12-19 3:47 pm Purchase | 2024-11-21 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Forbion Growth Opportunities Fund II Cooperatief U.A. | 3,452,330 7.300% | 3,452,330 (New Position) | Filing History |